Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

860 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor Extracellular Matrix Stiffness Promptly Modulates the Phenotype and Gene Expression of Infiltrating T Lymphocytes.
Chirivì M, Maiullari F, Milan M, Presutti D, Cordiglieri C, Crosti M, Sarnicola ML, Soluri A, Volpi M, Święszkowski W, Prati D, Rizzi M, Costantini M, Seliktar D, Parisi C, Bearzi C, Rizzi R. Chirivì M, et al. Among authors: rizzi r, rizzi m. Int J Mol Sci. 2021 May 30;22(11):5862. doi: 10.3390/ijms22115862. Int J Mol Sci. 2021. PMID: 34070750 Free PMC article.
In vivoorganized neovascularization induced by 3D bioprinted endothelial-derived extracellular vesicles.
Maiullari F, Chirivì M, Costantini M, Ferretti AM, Recchia S, Maiullari S, Milan M, Presutti D, Pace V, Raspa M, Scavizzi F, Massetti M, Petrella L, Fanelli M, Rizzi M, Fortunato O, Moretti F, Caradonna E, Bearzi C, Rizzi R. Maiullari F, et al. Among authors: rizzi r, rizzi m. Biofabrication. 2021 Apr 7;13(3). doi: 10.1088/1758-5090/abdacf. Biofabrication. 2021. PMID: 33434889
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers.
Filaci G, Fenoglio D, Fravega M, Ansaldo G, Borgonovo G, Traverso P, Villaggio B, Ferrera A, Kunkl A, Rizzi M, Ferrera F, Balestra P, Ghio M, Contini P, Setti M, Olive D, Azzarone B, Carmignani G, Ravetti JL, Torre G, Indiveri F. Filaci G, et al. Among authors: rizzi m. J Immunol. 2007 Oct 1;179(7):4323-34. doi: 10.4049/jimmunol.179.7.4323. J Immunol. 2007. PMID: 17878327
T cell immunity using transgenic B lymphocytes.
Gerloni M, Rizzi M, Castiglioni P, Zanetti M. Gerloni M, et al. Among authors: rizzi m. Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3892-7. doi: 10.1073/pnas.0400138101. Epub 2004 Mar 2. Proc Natl Acad Sci U S A. 2004. PMID: 15004284 Free PMC article.
Non-antigen specific CD8+ T suppressor lymphocytes.
Filaci G, Fravega M, Fenoglio D, Rizzi M, Negrini S, Viggiani R, Indiveri F. Filaci G, et al. Among authors: rizzi m. Clin Exp Med. 2004 Oct;4(2):86-92. doi: 10.1007/s10238-004-0042-3. Clin Exp Med. 2004. PMID: 15672945 Review.
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer.
Filaci G, Fravega M, Setti M, Traverso P, Millo E, Fenoglio D, Negrini S, Ferrera F, Romagnoli A, Basso M, Contini P, Rizzi M, Ghio M, Benatti U, Damonte G, Ravetti JL, Carmignani G, Zanetti M, Indiveri F. Filaci G, et al. Among authors: rizzi m. Blood. 2006 Feb 15;107(4):1505-12. doi: 10.1182/blood-2005-01-0258. Epub 2005 Oct 25. Blood. 2006. PMID: 16249379 Free article.
860 results